Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Lupus Discovery May Lead To Improved Drugs
Uncategorized

Lupus Discovery May Lead To Improved Drugs

By medwebMar 1, 2004
Share
Facebook Twitter Email

Lupus Discovery May Lead To Improved Drugs

In an important development for the treatment of lupus as well as certain cancers, scientists at the Feinberg School of Medicine at Northwestern University have discovered how autoimmune lupus T cells stave off programmed cell death and drive production of autoantibodies directed against the body’s own DNA.

Syamal K. Datta, MD, and colleagues found that lupus T cells increase production of an enzyme called cyclooxygenase 2 (COX-2), which helps trigger inflammation, in tandem with another molecule called c-FLIP, which then prevents the autoimmune T cells from self-destructing.

Using commonly prescribed drugs called COX-2 inhibitors, which suppress COX-2 activity and, as a result, inflammatory chemicals called prostaglandins, the Northwestern researchers caused autoimmune T cells to die and blocked lupus autoimmunity.

Results of their study, published in the April issue of Nature Medicine, may pave the way for the design of better COX-2 inhibitors with less kidney toxicity or other candidate drugs that interfere with the lupus T cell’s death resistance pathway, said Dr. Datta, who is professor of microbiology—immunology and medicine at the Feinberg School as well as Solovy Arthritis Research Society Professor.

COX-2 inhibitors are widely prescribed to treat rheumatoid arthritis and other inflammatory conditions and have been tested for use in a number of cancers, including colorectal cancer.

Most unexpectedly, the researchers found that only some COX-2 inhibitors have a beneficial effect in lupus. This may depend on their structural peculiarity and not because they inhibit prostaglandin production and reduce inflammation—something all COX-2 inhibitors do.

COX-2 inhibitors also have been used, with limited success, to treat patients with lupus and in laboratory models of lupus, but in doses much lower than the concentration required to achieve cell death and elimination of autoimmune T cells, Dr. Datta said.

Dr. Datta’s co-researchers were Luting Xu, Li Zhang, Yajun Yi, and Hee-Kap Kang. Yajun Yi is now at Vanderbilt University, Nashville.

This study was supported by grants from the National Institutes of Health.

Share. Facebook Twitter Email

Related Posts

Lurie Cancer Center Receives Merit Extension from NCI

Oct 20, 2021

Drug Combination May Reduce Risk of Leukemia Relapse

Mar 26, 2020

Rewriting the Role of a Transcription Factor

Mar 19, 2020

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.